J. Strohalm

6.1k total citations
90 papers, 5.2k citations indexed

About

J. Strohalm is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. Strohalm has authored 90 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 31 papers in Biomaterials and 28 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. Strohalm's work include Nanoparticle-Based Drug Delivery (27 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and RNA Interference and Gene Delivery (17 papers). J. Strohalm is often cited by papers focused on Nanoparticle-Based Drug Delivery (27 papers), Radiopharmaceutical Chemistry and Applications (17 papers) and RNA Interference and Gene Delivery (17 papers). J. Strohalm collaborates with scholars based in Czechia, United Kingdom and United States. J. Strohalm's co-authors include Karel Ulbrich, Ruth Duncan, Blanka Řı́hová, Vladimír Šubr, Leonard W. Seymour, Jindřich Kopeček, Jindřich Kopeček, Tomáš Etrych, D Plocová and M. Jelı́nková and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Biomaterials.

In The Last Decade

J. Strohalm

90 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Strohalm Czechia	40	2.7k	2.2k	1.3k	1.0k	868	90	5.2k
Blanka Řı́hová Czechia	43	2.8k 1.0×	1.7k 0.8×	1.6k 1.2×	978 1.0×	752 0.9×	140	5.0k
Samuel Zalipsky United States	42	3.3k 1.2×	3.9k 1.8×	1.5k 1.1×	1.2k 1.1×	614 0.7×	60	6.7k
Pavla Kopečková United States	52	3.3k 1.2×	2.9k 1.3×	1.8k 1.4×	1.5k 1.4×	1.2k 1.4×	136	7.2k
Tomáš Etrych Czechia	46	4.0k 1.5×	2.4k 1.1×	2.7k 2.0×	1.5k 1.4×	717 0.8×	217	6.7k
Jiyuan Yang United States	39	2.0k 0.7×	1.5k 0.7×	1.3k 1.0×	740 0.7×	600 0.7×	113	4.3k
Christopher P. Leamon United States	43	1.7k 0.6×	3.2k 1.5×	1.3k 0.9×	921 0.9×	1.7k 2.0×	94	6.6k
Rang‐Woon Park South Korea	35	2.0k 0.7×	2.1k 1.0×	1.3k 0.9×	376 0.4×	483 0.6×	54	4.6k
Matthias Barz Germany	40	2.6k 1.0×	2.5k 1.1×	1.2k 0.9×	2.1k 2.0×	258 0.3×	141	5.5k
Vladimir S. Trubetskoy United States	22	2.5k 0.9×	1.9k 0.9×	1.1k 0.8×	737 0.7×	186 0.2×	37	4.6k
Yuanpei Li United States	38	2.8k 1.0×	2.1k 1.0×	2.9k 2.2×	688 0.7×	477 0.5×	121	6.0k

Countries citing papers authored by J. Strohalm

Since Specialization

Citations

This map shows the geographic impact of J. Strohalm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Strohalm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Strohalm more than expected).

Fields of papers citing papers by J. Strohalm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Strohalm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Strohalm. The network helps show where J. Strohalm may publish in the future.

Co-authorship network of co-authors of J. Strohalm

This figure shows the co-authorship network connecting the top 25 collaborators of J. Strohalm. A scholar is included among the top collaborators of J. Strohalm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Strohalm. J. Strohalm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Šírová, Milada, J. Strohalm, Petr Chytil, et al.. (2016). The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel. Journal of Controlled Release. 246. 1–11. 24 indexed citations

Šírová, Milada, P Roßmann, Robert Pola, et al.. (2015). The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. Journal of Controlled Release. 223. 1–10. 35 indexed citations

Etrych, Tomáš, J. Strohalm, Petr Chytil, et al.. (2011). Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting. European Journal of Pharmaceutical Sciences. 42(5). 527–539. 92 indexed citations

Tomala, Jakub, J. Strohalm, Karel Ulbrich, et al.. (2010). Antitumor activity of IL‐2/anti‐IL‐2 mAb immunocomplexes exerts synergism with that of N‐(2‐hydroxypropyl)methacrylamide copolymer‐bound doxorubicin conjugate due to its low immunosuppressive activity. International Journal of Cancer. 129(8). 2002–2012. 7 indexed citations

Kovář, Lubomír, Tomáš Etrych, Vladimír Šubr, et al.. (2010). Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells. Tumor Biology. 31(4). 233–242. 19 indexed citations

Etrych, Tomáš, et al.. (2009). HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity. Journal of Controlled Release. 140(1). 18–26. 41 indexed citations

Hovorka, Ondřej, Tomáš Etrych, Vladimír Šubr, et al.. (2006). HPMA based macromolecular therapeutics: Internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition. Journal of drug targeting. 14(6). 391–403. 35 indexed citations

Řı́hová, Blanka, J. Strohalm, Kateřina Kubáčková, et al.. (2005). Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer. Kluwer Academic Publishers eBooks. 519. 125–143. 18 indexed citations

Poučková, P, M Zadinová, J. Strohalm, et al.. (2004). Polymer-conjugated bovine pancreatic and seminal ribonucleases inhibit growth of human tumors in nude mice. Journal of Controlled Release. 95(1). 83–92. 23 indexed citations

10.

Kovář, Marek, Tomáš Mrkvan, J. Strohalm, et al.. (2003). HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia. Journal of Controlled Release. 92(3). 315–330. 44 indexed citations

11.

Jelı́nková, M., J. Strohalm, Tomáš Etrych, Karel Ulbrich, & Blanka Řı́hová. (2003). Starlike vs. Classic Macromolecular Prodrugs: Two Different Antibody-Targeted HPMA Copolymers of Doxorubicin Studied in Vitro and in Vivo as Potential Anticancer Drugs. Pharmaceutical Research. 20(10). 1558–1564. 46 indexed citations

12.

Souček, J., P Poučková, J. Strohalm, et al.. (2002). Poly [N -(2-hydroxypropyl)methacrylamide] Conjugates of Bovine Pancreatic Ribonuclease (RNase A) Inhibit Growth of Human Melanoma in Nude Mice. Journal of drug targeting. 10(3). 175–183. 23 indexed citations

13.

Hovorka, Ondřej, Martin Šťastný, Tomáš Etrych, et al.. (2002). Differences in the intracellular fate of free and polymer-bound doxorubicin. Journal of Controlled Release. 80(1-3). 101–117. 66 indexed citations

14.

Wu, Jun, Ruth Duncan, J. Strohalm, et al.. (1998). Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues. Japanese Journal of Cancer Research. 89(3). 307–314. 370 indexed citations

15.

Ulbrich, Karel, Michal Pechar, J. Strohalm, Vladimír Šubr, & Blanka Řı́hová. (1997). Synthesis of Biodegradable Polymers for Controlled Drug Release^a. Annals of the New York Academy of Sciences. 831(1). 47–52. 27 indexed citations

16.

Ulbrich, Karel, et al.. (1996). Polymeric conjugates of drugs and antibodies for site‐specific drug delivery. Macromolecular Symposia. 103(1). 177–192. 42 indexed citations

17.

Pimm, M. V., Alan C. Perkins, J. Strohalm, Karel Ulbrich, & Ruth Duncan. (1996). Gamma Scintigraphy of the Biodistribution of¹²³I-Labelled N-(2-Hydroxypropyl)methacrylamide Copolymer-Doxorubicin Conjugates in Mice with Transplanted Melanoma and Mammary Carcinoma. Journal of drug targeting. 3(5). 375–383. 38 indexed citations

18.

Seymour, Leonard W., Karel Ulbrich, Stephen R. Wedge, et al.. (1991). N-(2-Hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice. British Journal of Cancer. 63(6). 859–866. 94 indexed citations

19.

Bilej, Martin, Václav Větvička, Karel Ulbrich, et al.. (1989). Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Biomaterials. 10(5). 335–342. 177 indexed citations

20.

Duncan, Ruth, et al.. (1988). Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. British Journal of Cancer. 57(2). 147–156. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact